NCT05693220 Sperm Preparation Prior to Intrauterine Insemination Study
| NCT ID | NCT05693220 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Infertility |
| Study Type | INTERVENTIONAL |
| Enrollment | 270 participants |
| Start Date | 2023-02-05 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 270 participants in total. It began in 2023-02-05 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized controlled trial comparing density gradient centrifugation and microfluidic sperm sorting in patients undergoing intrauterine insemination to evaluate cumulative pregnancy outcomes.
Eligibility Criteria
Inclusion Criteria: * Patients undergoing intrauterine insemination * Patient assigned female at birth with age \<41 Exclusion Criteria: * Any significant disease or psychiatric disorder that would interfere with the consenting process * Prior intrauterine insemination * Use of frozen donor sperm * Non-English speaker
Contact & Investigator
Mitchell Rosen, MD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT05693220 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Infertility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05693220 currently recruiting?
Yes, NCT05693220 is actively recruiting participants. Contact the research team at alisha.tolani@ucsf.edu for enrollment information.
Where is the NCT05693220 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT05693220 clinical trial?
NCT05693220 is sponsored by University of California, San Francisco. The principal investigator is Mitchell Rosen, MD at University of California, San Francisco. The trial plans to enroll 270 participants.